MarketsandMarkets analysis says that a Potential Opportunity Worth $50 Bn is opening up in Genomics2/14/2022 As Genome Sequencing heads to $100 Direct-to-Consumer, a potential opportunity worth $50 Bn is expected to open up, leading to a million terabytes of genome data by 2025.
The genome sequencing market will reach $25 Bn by 2026, further intensified by COVID-19, and oncology and rare disease diagnostics coupled with pan genome studies. Adjacent markets of data storage, high performance computing (HPC), lab automation, and AI are anticipated to see unlocking of a further $20 Bn. Download PDF Brochure: https://www.marketsandmarkets.com/practices/pdfdownload.asp?p=genomics According to MarketsandMarkets analysis, $50 Bn of potential opportunity is opening up as genome sequencing heads to $100 direct-to-consumer, which was one of the most talked-about trends in 2021. The global genomic studies and projects comprising advanced genetic sequencing is expected to drive better clinical decision-making in the coming years, presenting lucrative growth opportunities to NGS companies. Additionally, the life sciences market is witnessing an increased adoption of AI, personalized healthcare, gene editing, etc., which is likely to disrupt the demand for genomics, in turn impacting the growth of the market. The increasing demand for sequencing and bioinformatics in diagnostics is predicted to disrupt the demand for IVD over the next few years. MarketsandMarkets is focused on high-growth, niche markets, such as AI in genomics, spatial genomics & transcriptomics, liquid biopsy, single-cell analysis, and related markets, providing a comprehensive understanding of the entire genomics ecosystem through the World’s First Market Intelligence Cloud, ‘KnowledgeStore’. It helps find blind spots in clients’ revenue decisions because of interconnections and unknowns that impacting clients and their client’s clients. For more details, please visit: https://www.marketsandmarkets.com/practices/genomics-new.asp Press Release: https://www.marketsandmarkets.com/PressReleases/genomics.asp
0 Comments
According to the new market research report "Digital X-ray Market by Portability (Fixed, Portable), Applications (General, Dental, Mammography, Cancer, Fluoroscopy), Technology (Direct, Computed), System (Retrofit, New), End Users, Price Range, Type, and Region - Global Forecast to 2026", published by MarketsandMarkets™, the market is expected to reach USD 16.4 billion by 2026 from an estimated USD 11.1 billion in 2021, at a CAGR of 8.1% from 2021 to 2026.
Browse in-depth TOC on "Digital X-ray Market" 230 – Tables 45 – Figures 280 – Pages Download PDF Brochure: :-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1164 The major factors driving the growth of this market include the increasing geriatric population and growth in disease incidence as well as favorable government regulations, investments, and initiatives. The advantages of digital X-ray systems have played a key part in their adoption; their speed and accuracy, as well as quick processing times, allow for significantly higher patient screening volumes than earlier. This has pushed companies to focus on product development and innovation. The direct radiography segment dominated the digital X-ray market in 2020 Based on technology, the market is segmented into direct radiography and computed radiography. The direct radiography segment commanded the largest share of the global market in 2020. The major benefit of DR-based systems over film and CR systems is that images are sent directly to a computer screen from the X-ray imaging plate, thereby eliminating the need to retrieve the image plate for processing images or taking a second X-ray shot. An effective dynamic range, better medical evaluation, superior and accurate image capture, reduced radiation exposure for patients and workers, flexibility in image management, improved patient throughput, superior evaluation of data and images, and lower operational costs are some of the other advantages of DR systems. Due to these advantages, the use of DR systems is on the rise. Portable digital X-ray systems are expected to register the highest CAGR during the forecasted period Based on portability, the digital X-ray market is segmented into fixed digital X-ray systems and portable digital X-ray systems. Fixed digital X-ray systems include floor-to-ceiling-mounted systems and ceiling-mounted systems, while portable digital X-ray systems include mobile X-ray systems and handheld X-ray systems. The portable digital X-ray systems are expected to grow with the highest CAGR during the forecasted period. Portable X-ray systems are light and can be transported to any desired location. These systems are especially useful in a variety of radiographic imaging set-ups, including intensive care units, cardiac care units, neonatal intensive care units, operating rooms, emergency rooms, and at the patient's bedside for critically ill patients or patients with mobility challenges. Request Sample Pages: :-https://www.marketsandmarkets.com/requestsampleNew.asp?id=1164 The retrofit digital X-ray systems segment dominated the digital X-ray market in 2020 The global digital X-ray systems market is divided into new and retrofit digital X-ray systems. The retrofit digital X-ray systems segment is expected to dominate the market during the forecast period. The large share of this segment can be attributed to the greater adoption of retrofit systems among end users due to their lower cost compared to new digital X-ray systems. Hospitals were the key end-users in the digital X-ray market in 2020 Based on end users, the X-ray market is segmented into diagnostic centers, hospitals, and dental care centers. Hospitals are expected to dominate the market during the forecast period. Hospitals constantly require advanced diagnostic systems that enable the screening and diagnosis of a large number of patients in a short time period. This is a key factor driving market growth. The general applications segment dominated the digital X-ray market by applications in 2020 Based on applications, the market is segmented into general radiography, dental applications, fluoroscopy, cancer, and mammography applications. The general radiography segment is expected to dominate this market during the forecast period. Growth in this market can be attributed to the increasing prevalence of target diseases, high demand for early diagnosis and diagnostic imaging, and technological advancements in the digital X-ray systems market. Speak to Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=1164 Asia Pacific is expected to see the highest growth in the digital X-ray market by region The digital X-ray market is segmented into five major regions—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is the largest regional market for digital X-ray systems, whereas the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. Growth in the digital X-ray market in the Asia Pacific is mainly driven by the growing geriatric population, particularly in Japan; increasing disposable incomes, allowing for greater affordability for advanced technologies; the rising prevalence of target diseases; and favorable government initiatives. Such factors help to drive the market for digital imaging systems in this region and draw foreign investments and partnerships. The digital X-ray market is dominated by Siemens Healthineers (Germany), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), FUJIFILM Holdings Corporation (Japan), and Canon, Inc. (Japan). The other leading market players include Carestream Health (US), Shimadzu Corporation (Japan), Hologic Inc. (US), Agfa-Gevaert Group (Belgium), Samsung Medison (South Korea), and Konica Minolta (Japan). Browse Related Reports: Nuclear Imaging Equipment Market by Product (SPECT (Hybrid SPECT, Standalone SPECT), Hybrid PET, & Planar Scintigraphy), Application (Oncology, Cardiology & Neurology) & End user (Hospitals, Imaging Centers) - Global Forecasts to 2025https://www.marketsandmarkets.com/Market-Reports/nuclear-imaging-equipment-market-98.html CBCT/Cone Beam Imaging Market by Application (Dental (Oral and Maxillofacial Surgery, Implantology, Orthodontics, Endodontics), Patient Position (Standing/Sitting, Seated, Supine), End User (Hospital, Private Practice) - Global Forecast to 2021https://www.marketsandmarkets.com/Market-Reports/cone-beam-imaging-market-226049013.html Hollow Fiber Filtration Market worth $597 million by 2026 - Exclusive Report by MarketsandMarkets™2/10/2022 According to the new market research report "Hollow Fiber Filtration Market by Material (Polymer (PES, PVDF), Ceramic), Technique (Microfiltration, Ultrafiltration), Application (Harvest & Clarification, Concentration, Diafiltration), End Users (Pharma, Biotech, CRO, CMO) - Global Forecast to 2026", published by MarketsandMarkets™, is projected to reach USD 597 million by 2026 from USD 303 million in 2021, at a CAGR of 14.5% during the forecast period.
Browse and in-depth TOC on "Hollow Fiber Filtration Market" 194 - Tables 35 - Figures 184 – Pages Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=267011039 The growth of the global Hollow Fiber Filtration Market is driven by factors such as the rising preference for continuous manufacturing, increasing use of single use technologies, and the rising biopharmaceutical industry. In addition, emerging economies, and increased investment cell-based research are expected to provide significant growth opportunities for players in the market. The PS/PES material segment accounted for the largest share of the Hollow Fiber Filtration Market in 2020. Based on material, the market is segmented into polymeric and ceramic. The polymeric segment is further sub segmented into PS/PES, Polyvinylidene fluoride (PVDF), and Other polymeric materials. In 2020, PS/PES membrane filters accounted for the largest market share as they are designed to eliminate particulates during standard filtration. They have low protein and drug binding characteristics and are stable at alkaline pH. PS/PES membranes are recommended for aqueous applications and for biological samples. These membranes offer high product recoveries due to characteristics such as low affinity and adsorption. In biopharmaceutical industries, PS/PES membranes are mostly used for ultrafiltration in downstream processing, product concentration, and the filtration of biological and pharmaceutical solutions. The continuous cell perfusion segment accounted for the largest market share of the Hollow Fiber Filtration Market in 2020. Based on application type, the market is segmented into continuous cell perfusion, harvest and clarification, and concentration and diafiltration. In 2020, continuous cell perfusion accounted for the largest market share due to the advantages of hollow fibers in continuous cell perfusion, such as enabling efficient cell separation (with low shear) and allowing robust large-scale manufacturing. Request Sample Pages:-https://www.marketsandmarkets.com/requestsampleNew.asp?id=267011039 The Asia Pacific region is the fastest-growing region of the Hollow Fiber Filtration Market in 2020. The Asia Pacific market is projected to witness the highest growth rate during the forecast period, primarily due to innovation, a giant talent pool of scientists, low labor, and manufacturing costs. The region has also witnessed mass production because of technology and a rise in continuous manufacturing instead of batch production in the previous era. Asia Pacific region is also a lucrative market for foreign investors, with key market players having their presence in the region. Over the last decade, CMOs in the Asia Pacific region have impacted the global pharmaceutical manufacturing market. Several small and medium-scale CMOs set up in APAC have obtained US FDA approval for their operations and completed GMP certifications, thus driving the regions market. Prominent players in the Hollow Fiber Filtration Market are Repligen Corporation (US), Danaher (US), Asahi Kasei Corporation (Japan), Parker-Hannifin Corp (US), Sartorius Stedim Biotech S.A (France), TOYOBO CO., LTD (Japan), and Cantel Medical (US). The key players in this market are focusing on strategic expansions, and acquisition to expand their presence in the market. Browse Related Reports: Pharmaceutical Membrane Filtration Market by Product (Filter, System), Technique (Microfiltration, Nanofiltration), Material (PES, PVDF, PTFE), Application (Final Product (Sterile Filtration), Raw Material, Cell Separation, Water) - Global Forecast to 2025 https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-membrane-filtration-market-255408031.html Pharmaceutical Filtration Market by Product (Membrane Filters, Single-Use Systems), Technique (Microfiltration, Ultrafiltration), Application (Final Product Processing, Raw material), Scale of Operation (Manufacturing, Pilot, R&D) - Global Forecast to 2021https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-filtration-market-209343847.html According to the new market research report "Nerve Repair and Regeneration Market by Products (Nerve Conduits, Nerve Wraps, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Spinal Cord Stimulation, TENS, TMS), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) and Region - Global Forecast to 2025", published by MarketsandMarkets™, the global Nerve Repair and Regeneration Market size is projected to reach USD 9.7 billion by 2025 from USD 6.3 billion in 2020, growing at a CAGR of 9.1% from 2020 to 2025.
Browse in-depth TOC on "Nerve Repair and Regeneration Market" 142 – Tables 43 – Figures 167 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=883 The Growth in Nerve Regeneration Market is driven mainly by high incidence of nerve injuries, the growing prevalence of neurological disorders, and rising government support for neurologic disorder research. Neurostimulation and Neuromodulation Devices accounted for the largest share of the market, by product, in 2019 By product, the nerve repair market is segmented into neurostimulation and neuromodulation devices and biomaterials. The neurostimulation and neuromodulation devices segment is segment is expected to grow at the highest growth rate during the forecast period. The large market share of this segment is driven mainly by rising government expenditure for neurologic disorders, and favorable reimbursement . By neurostimulation and neuromodulation application, internal neurostimulation and neuromodulation accounted for the largest market share in 2019 Based on the neurostimulation and neuromodulation application , the Nerve Regeneration Market is segmented the neurostimulation and neuromodulation devices market is segmented into internal neurostimulation and neuromodulation applications and external neurostimulation and neuromodulation applications. The internal neurostimulation and neuromodulation segment is estimated to register the highest CAGR during the forecast period. This can primarily be attributed to the increasing incidence of neurological disorders across the globe. By Biomaterials application, direct nerve repair/neurorrhaphy accounted for the largest market share in 2019 Based on application, the biomaterials market is segmented into direct nerve repair/neurorrhaphy, nerve grafting, and stem cell therapy. In 2019, the direct nerve repair segment accounted for the largest share of the market. This can be attributed to the increasing incidence of neurological disorders across the globe. Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=883 North America was the largest regional market for Nerve Repair Market in 2019 The Nerve Repair And Regeneration Market is segmented into five major regions, namely, Europe, North America, the Asia Pacific, Latin America, and Middle East & Africa. In 2019, North America accounted for the largest share of the Nerve Regeneration Market, followed by Europe. The rising incidence of neurological disorders, favorable reimbursement policies, and the strong presence of industry players in the region are the major factors driving the growth of the market in North America. Some of the major players operating in the global Nerve Repair And Regeneration Market include Medtronic, PLC. (Ireland), Boston Scientific Corporation (US), Abbott Laboratories (US), AxoGen, Inc. (US), Baxter International, Inc. (US), LivaNova, PLC. (UK), Integra LifeSciences (US), Polyganics (Netherlands), NeuroPace, Inc. (US), Soterix Medical, Inc. (US), Nevro Corp (US), Synapse Biomedical, Inc. (US), Aleva Neurotherapeutics (Switzerland), Collagen Matrix, Inc. (US), KeriMedical (Switzerland), BioWave Corporation (US), NeuroSigma (US), tVNS Technologies GmbH(Germany), and GiMer Medical (Taiwan). Browse Related Reports: Stem Cell Therapy Market by Type (Allogeneic, Autologous), Therapeutic Application (Musculoskeletal, Wound & Injury, CVD, Autoimmune & Inflammatory), Cell Source (Adipose tissue, Bone Marrow, Placenta/Umbilical Cord) - Global Forecasts to 2026https://www.marketsandmarkets.com/Market-Reports/stem-cell-technologies-and-global-market-48.html According to the new market research report "Research Antibodies and Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blotting, Flow Cytometry), Application (Proteomics, Drug Development), End User - COVID-19 Impact - Global Forecast to 2025", published by MarketsandMarkets™, the global market size is projected to reach USD 14.1 billion by 2025 from USD 10.1 billion in 2020, at a CAGR of 6.7% during the forecast period.
The growth is due to evolution of market owing to factors such as growth in proteomics and genomics research, rising demand for high-quality antibodies for research reproducibility, and increasing R&D activity and expenditure in the life sciences industry. Fueled by the growing demand for personalized medicine and structure-based drug design, the global market is expected to witness significant growth in the coming years. Browse in-depth TOC on "Research Antibodies and Reagents Market" 220 – Tables 45 – Figures 278 – Pages Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94212793 The COVID-19 outbreak has boosted research activity due to efforts to understand the dynamics of the infection. We estimate that the major share of research antibody and reagent manufacturing, along with personalized medicine, will grow at a stable pace in the next five years. Due to the increase in research activity, both the availability of funding for research and the demand & manufacturing of reagents and antibodies are expected to grow. As companies after pandemic have scaled up their operations for testing and tracking the infection of COVID-19. This has given a chance for growth in profits for companies operating in the NGS and PCR markets. The growth in revenue is 5–7%, as COVID-19 testing has increased with the use of the latest technology of genetic and molecular testing. The shift in demand for research for COVID-19, neurobiology, and oncology has created a huge scope for testing solutions, such as western blotting, flow cytometry, ELISA, and drugs for researchers and laboratories. The antibodies segment is expected to grow at the highest CAGR during the forecast period Based on product, the research antibodies market is segmented into reagents and antibodies. The antibodies segment is expected to grow at highest CAGR in forecast period. This is due to the research-use antibodies offer high specificity and selectivity and are used ubiquitously in biochemical and medical research for protein-target identification, regulatory characterization, and discovery. The primary antibodies segment is accounts for the largest share of the research reagents market Based type, the research reagents market is segmented into primary antibodies and secondary antibodies. The primary antibodies segment held the largest share of the global research antibodies market in 2019. This segment is witnessing a strong growth due to the use of these antibodies in numerous types of assay formats. Their accuracy in biomarker detection and their high specificity and sensitivity are also driving their adoption The media & sera reagent is expected to account for the largest share of the market, by type, in 2019 Based type, the research antibodies and reagents market is segmented into media &sera, stains & dyes, fixatives, buffers, solvents, enzymes, probes and other reagents. The media & sera reagent segment held the largest share of the global research antibodies market in 2019. The large share of this segment is primarily attributed to the use of these components in all types of assays, cell cultures, and techniques. The western blotting segment is expected to account for the largest share of the market, by technology, in 2019 Based on technology, the research antibodies market is segmented into western blotting, flow cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, and other technologies. Western blotting segment is expected to grow at highest CAGR in forecast periods (2020-2025). This is due to the high adoption of this technique in proteomic and genomic research. The results achieved are easy to interpret, unique, and unambiguous, making it suited for evaluating levels of protein expression in cells, monitoring fractions during protein purification, and comparing the expression of a target protein from various tissues. The pharmaceutical & biotechnology segment is expected to grow at the highest CAGR during the forecast period Based on end user, the research reagents market is segmented into the pharmaceutical & biotechnology companies, academic & research institutions and Contract Research Organizations. The growth of this segment is due to antibodies provide a gold standard for the detection of a biomolecule or a pathway and are even capable of detecting specific changes in potential drug targets. Additionally, highly specific reagents are used to measure pharmacokinetic parameters in the preclinical and clinical development of biological drugs. The increasing demand for personalized medicine and government initiatives in this sector are the key market drivers for this segment. Get Data as per your Format and Definition | REQUEST FOR CUSTOMIZATION:-https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=94212793 The APAC market is expected to grow at the highest CAGR during the forecast period The Asia Pacific research reagents market is expected to grow at the highest CAGR from 2020 to 2025.The growth of this market is primarily due to growing proteomics and genomics research and increasing research funding, investments by pharmaceutical and biotechnology companies, and growing awareness of personalized therapeutics in the region. Also, high-growth countries, such as China, India, Japan, South Korea, Taiwan, Australia, and Singapore are the major contributors to the Asia Pacific research antibodies and reagents market. This region is expected to grow at the highest pace during the forecast period primarily due to growing proteomics and genomics research and increasing research funding, increasing investments by pharmaceutical and biotechnology companies, and growing awareness about personalized therapeutics. The prominent market players are Thermo Fisher Scientific (US), Merck Group (Germany), Abcam plc (UK), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Cell Signaling Technology (US), F. Hoffmann-La Roche (Switzerland), Danaher Corporation (US), Agilent Technologies (US), PerkinElmer (US), Lonza (Switzerland), GenScript (China), and BioLegend (US). Browse Related Reports: Flow Cytometry Market by Technology (Cell-based, Bead-based), Product (Analyzer, Sorter, Reagents, Consumables, Software), End user (Academia, Research Labs, Hospitals, Clinical Laboratories, Pharma-Biotech Cos), Application - Global Forecasts to 2025 https://www.marketsandmarkets.com/Market-Reports/flow-cytometry-market-65374584.html According to the new market research report "Animal Antibiotics and Antimicrobials Market by Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Lincosamide), Mode of Delivery (Premixes, Oral Solution, Injection), Animal (Food producing & Companion) - Global Forecast to 2026", published by MarketsandMarkets™, the global Animal Antimicrobials Market is projected to reach USD 5.6 billion by 2026 from USD 4.7 billion in 2021, at a CAGR of 3.6% from 2021 to 2026.
Browse in-depth TOC on "Animal Antibiotics and Antimicrobials Market" 151 – Tables 35 – Figures 152 – Pages Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=25161353 The animal antibiotics market growth can largely be attributed to the rising demand for animal-derived food products, increasing incidence of zoonotic diseases, and the implementation of regulations to prevent the spread of animal diseases. Rising animal healthcare spending and the growing demand for pet insurance are further expected to drive the growth of this market. The untapped emerging markets such as China, India, and Brazil and growth in the overall companion animal population are also expected to offer significant growth opportunities to market players in the coming years. However, the limited number of new antibiotics, growing resistance to antimicrobials and antibiotics, and increasing good husbandry and hygiene practices are expected to hinder the growth of this market to a certain extent. The Tetracyclines segment accounted for the largest market share in 2020. Based on products, the global animal antimicrobials and antibiotics market is segmented into tetracyclines, penicillins, sulfonamides, macrolides, aminoglycosides, lincosamides, fluoroquinolones, cephalosporins, and other antimicrobial and antibiotic products. In 2020, the tetracyclines segment accounted for 48.9% of the global animal antimicrobials market. Tetracyclines exhibit advantages such as the highest potency against pathogenic microorganisms, are well-absorbed, show low toxicity, and are relatively inexpensive compared to other animal antimicrobial and antibiotic products. These advantages contribute to the large share of this product segment. The fluoroquinolones segment is expected to grow at the highest CAGR of 8.0% during the forecast period. Advantages such as higher efficacy at low concentrations, quick penetration through tissues, and the availability of variations in the route of administration result in the higher adoption of fluoroquinolones among end users. The Premixes segment accounted for the largest market share in 2020. Based on the mode of delivery, the global animal antimicrobials and antibiotics market is segmented into premixes, oral powders, oral solutions, injections, and other modes of delivery. In 2020, the premixes segment accounted for the largest share of 46.3% of the global animal antibiotics market. The large share of this segment can be attributed to the advantages of premixes, such as simplified mode of administration and lower instability and hygroscopicity of formulations. The injections segment is expected to witness the highest CAGR of 4.9% during the forecast period. Advantages such as immediate delivery of drugs and rapid onset of drug effects are expected to drive growth in this market. The food producing animal segment accounted for the largest market share in 2020. Based on animal type, the global animal antimicrobials and antibiotics market is categorized into food-producing animals and companion animals. In 2020, the food-producing animals segment accounted for the largest share of around 73.4%. This segment is also expected to register the highest CAGR of 3.9% during the forecast period. The large share of this segment is mainly due to the rising demand for animal-derived food products, increase in animal healthcare expenditure, and greater concerns about zoonotic diseases. Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=25161353 North America was the largest regional market for animal antibiotics market in 2020 The animal antimicrobials and antibiotics market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of 30.3% of the global animal antimicrobials market. The large share of this region is mainly due to the increase in the region's animal population, rising demand for animal-derived food products, growth in pet insurance, and rising animal health expenditure compared to other regions. The Asia Pacific region is projected to grow at the highest CAGR of 5.4% during the forecast period. Factors such as the rapidly increasing animal population and rising demand for animal-derived food products are driving the growth of this market in the APAC. Some of the prominent players in the animal antimicrobials and antibiotics market are Boehringer Ingelheim (Germany), Zoetis Inc. (US), Elanco Animal Health (US), Merck & Co. Inc (US), Phibro Animal Health (US), Virbac (France), Vetoquinol S.A. (France), Ceva Santé Animale (France), Dechra Pharmaceuticals Plc (UK), Kyoritsu Seiyaku (Japan), Tianjin Ringpu (China), HIPRA (Spain), Zydus Animal Health (US), China Animal Husbandry (China), and Inovet (Belgium). Browse Related Reports: Animal Growth Promoters and Performance Enhancers Market by Product Antibiotic and Non-antibiotic (Hormones, Acidifiers, Feed Enzymes, Probioitcs & Prebiotics, Phytogenics), Animal (Poultry, Porcine, Livestock, Aquaculture) - Global Forecast to 2026 https://www.marketsandmarkets.com/Market-Reports/animal-growth-promoters-performance-enhancers-market-137134167.html According to the new market research report " Healthcare EDI Market by Component (Solution, Service), Delivery Mode (On-premise & Cloud, Mobile) Transaction Type (Claims Management, Payment Remittance, Payments, Healthcare Supply Chain), End-User & Region - Global Forecast to 2025", published by MarketsandMarkets™, the market is projected to reach USD 4.4 billion by 2025 from USD 3.0 billion in 2020, at a CAGR of 7.8% during the forecast period.
Browse in-depth TOC on "Healthcare EDI Market" 129 – Tables 44 – Figures 195 – Pages Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=130571438 The growth of this market is majorly attributed to the development of regulations for transaction processes, the rising need to curtail healthcare costs and government support for HCIT implementation. Also, the need for the efficient management of electronic claims and reimbursement transactions (for healthcare providers) is expected to drive demand growth in the healthcare EDI market during the forecast period. By delivery mode, the mobile EDI segment is expected to grow at the highest growth rate during the forecast period Among the delivery mode segment, the mobile EDI segment is expected to grow at the highest CAGR during the forecast period. The factors attributing to the high growth of this segment include the technological upgrades in the healthcare industry and growing acceptance of mobile solutions among healthcare providers. By component, the services segment is expected to record the highest CAGR during the forecast period The services segment is expected to witness a faster growth rate in this market due to factors such as, the increasing claims volume, increasing complexity, and scale of EDI solutions, as they require extensive training programs. Similarly, a growing trend of outsourcing activities, such as revenue cycle management, claims handling and management, and partner management services is also expected to propel the growth of the services market. By transaction type, the claims management segment is expected to account for the largest share of the healthcare EDI market On the basis of the transaction type, the EDI market is segmented into claims management and healthcare supply chain. The claims management segment is expected to account for the largest share of the market during the forecast period. The large share of this segment can be attributed to the rising adoption of EDI services by healthcare providers and payers and the need to meet regulatory requirements. By end user, the healthcare payers segment to record the highest CAGR during the forecast period Based on end user, the healthcare EDI market is segmented into healthcare providers, healthcare payers, medical device & pharmaceutical industries, and pharmacies. The healthcare payers segment is expected to grow at the highest CAGR during the forecast period due to the increasing number of private insurance players in the market. Get 10% Customization on this Research Report: -https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=130571438 North America dominates the Healthcare EDI market during the forecast period. North America is expected to hold the largest market size in the global market during the forecast period, followed by the European region. The rising HCIT expenditure, developed healthcare infrastructure, broad insurance coverage, a favorable regulatory scenario, an increasing number of private healthcare players, growing demand for healthcare supply chain management solutions, and the presence of prominent healthcare IT companies in this region, are responsible for the large share of the North American EDI market. McKesson Corporation (US), Optum (US), Allscripts Healthcare Solutions Inc. (US), athenahealth (US), and Nextgen Healthcare (US) are the key players operating in the healthcare EDI market. Other prominent players in this market include Cognizant Technology Corporation (US), SSI Group, LLC (US), Cerner Corporation (US), Comarch SA (Poland), Axway Software SA (France), Optum Inc. (US), Dell Technologies Inc. (US), Nextgen Healthcare (US), Synnex Corporation (US), Comarch (Poland), Axway Solutions (US), and Plexis Healthcare Systems (US). Browse Related Reports: Revenue Cycle Management/RCM Market by Product & Services (Eligibility Verification, Clinical Coding, CDI, Claims Processing, Denial Management, Outsourcing Services, Cloud), End User(Payers, Hospitals, Outpatient), Covid-19 Impact - Global Forecast to 2026https://www.marketsandmarkets.com/Market-Reports/revenue-cycle-management-market-153900104.htmlHealthcare Interoperability Solutions Market by Type (EHR Interoperability, Health Information Exchange, Enterprise), Interoperability Levels (Foundational, Structural, Semantics), End User and Region - Global Forecast to 2026https://www.marketsandmarkets.com/Market-Reports/healthcare-interoperability-solution-market-17705847.html Patient Registry Software Market worth $2.8 billion by 2026 - Exclusive Report by MarketsandMarkets™2/1/2022 According to the new market research report "Patient Registry Software Market by Type of Registry (Diabetes, Cancer, Rare Disease, Asthma, Kidney), Software (Integrated and Standalone), Delivery (On Premise and Cloud), Pricing Model, Database (Public), End User (Hospitals) - Global Forecast to 2026," published by MarketsandMarkets™, the Patient Registry Software Market is projected to reach USD 2.8 billion by 2026 from USD 1.4 billion in 2021, at a CAGR of 15.0% during the forecast period.
Browse in-depth TOC on "Patient Registry Software Market" 224 – Tables 45 – Figures 286 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144694594 The growth of this market is mainly attributed to the shift toward computerized registries to provide users with an automated way to store data and create, sort, and display patient lists for use in planning, quality improvement, reporting, and direct care delivery. Also, the emergence of the COVID-19 pandemic and the increasing number of COVID-19 patients globally are expected to increase the demand for patient registry software in the coming years. The base year considered for the study is 2020, while, the forecast period is 2021 to 2026. By type of registry, the disease registries segment accounted for the largest share of the patient registry software market in 2020. On the basis of type of registry, the disease registries segment accounted for the largest share of the patient registry software market in 2020. The large share of this segment can be attributed to the increase in the aging population, rising prevalence of chronic and rare & new diseases, growing awareness on the role of registries in health management, and the adoption of EHRs across the globe. The hospitals & medical practices segment is expected to witness the highest growth rate in the patient registry software market, by end user, during the forecast period Based on end user, the hospitals & medical practices segment is expected to register the highest CAGR during the forecast period. Factors responsible for the growth of this segment are growing prevalence of research, QM and improvement, facility planning and marketing, and monitoring patient outcomes. Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=144694594 North America dominated the patient registry software market in 2020 North America accounted for the largest share of the market in 2020, followed by Europe and Asia Pacific. The increasing need to integrate healthcare systems, government funding for developing patient registries, rising focus on PHM and HIE, increasing adoption of HCIT as a cost-containment measure are some of the factors driving the growth of the market in North America. Some of the prominent players in this patient registry software market are IBM Corporation (US), IQVIA Holdings (US), OpenText Corporation (Canada), Optum (US), Premier, Inc. (US), ArborMetrix, Inc. (US), FIGmd (US), McKesson Corporation (US), Syneos Health (US), Dacima Software, Inc. (Canada), ifa Systems AG (Germany), Medstreaming- M2S (US), ImageTrend, Inc. (US), Evado Clinical (Australia), WIRB Copernicus Group (US), Global Vision Technologies, Inc. (India), Conduent, Inc. (US), Elekta AB (Sweden), Cedaron (US), LUMEDX (US), Armus Corp (US), Phamax AG (Switzerland), and Versaform Systems Corp (US), ESO Solutions (US) and Ordinal Data, Inc. (US). |
AuthorWe are providing and consulting the healthcare Industry Research Report. Archives
March 2022
Categories |